ArticleScientific reports2021

Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.

Adam J Davenport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.